Policy approach to optimize multiple myeloma treatment sequencing practices

Uncertainty plays a central role in shaping sequencing practices in MM, underscoring the need for better evidence to guide decisions and avoid suboptimal use of treatment options. As the therapeutic landscape continues to expand, sequencing will be even more complex, which necessitates international coordinated efforts. The multi-stakeholder discussion presented here represents an initial step toward enabling such joint actions.